Search
Now showing items 1-6 of 6
HIV Subtype D Is Associated with Dementia, Compared with Subtype A, in Immunosuppressed Individuals at Risk of Cognitive Impairment in Kampala, Uganda
(Clinical Infectious Diseases, 2009)
Background. In the United States, clade B is the predominant human immunodeficiency virus (HIV) subtype,
whereas in sub-Saharan Africa, clades A, C, and D are the predominant subtypes. HIV subtype may have an impact
on ...
Clinical presentation of bipolar mania in HIV-positive patients in Uganda.
(American Psychiatric Publishing, 2009)
Background: Secondary mania in HIV-positive individuals has been well documented; however, cases of bipolar mania in HIV infection occur, as well. Objective: This is the first controlled study of the demographic and clinical ...
Cognitive dysfunction among HIV positive and HIV negative patients with psychosis in Uganda
(Public Library of Science, 2012)
Background: Cognitive impairment is an established phenomenon in HIV infected individuals and patients that have
psychosis. However there is need to establish the severity of the impairment if patients are co morbid with ...
Pattern of neuropsychological performance among HIV positive patients in Uganda
(BioMed Central, 2007)
Background: Few studies have examined cognitive functioning of HIV positive patients in sub-Saharan Africa. It cannot be assumed that HIV positive patients in Africa exhibit the same declines as patients in high-resource ...
The International HIV Dementia Scale: a new rapid screening test for HIV dementia
(Lippincott Williams & Wilkins, 2005)
Objective: HIV dementia is an important neurological complication of advanced HIV infection. The use of a cross-cultural screening test to detect HIV dementia within the international community is critical for diagnosing ...
Early-onset versus late-onset HIV-related secondary mania in Uganda.
(2008)
Background: First-episode secondary mania in human immunodeficiency virus (HIV) infection has been described among samples of predominantly Caucasian, HIV-positive male patients in developed countries. Objective: The goal ...